Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 36, Issue 7, Pages 781-796
Publisher
Wiley
Online
2016-06-11
DOI
10.1002/phar.1780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Marijuana's Medical Future
- (2015) David Noonan SCIENTIFIC AMERICAN
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
- (2014) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal
- (2014) David J. Allsop et al. JAMA Psychiatry
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Stiripentol: An example of antiepileptic drug development in childhood epilepsies
- (2012) Rima Nabbout et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Incidence and prevalence of epilepsy among older US Medicare beneficiaries
- (2012) E. Faught et al. NEUROLOGY
- Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
- (2012) Valéria Almeida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cannabinoids, endocannabinoids, and cancer
- (2011) Daniel J. Hermanson et al. CANCER AND METASTASIS REVIEWS
- Current therapeutic procedures in Dravet syndrome
- (2011) CATHERINE CHIRON DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Phytocannabinoids beyond the Cannabis plant - do they exist?
- (2010) J������rg Gertsch et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Treatment of Lennox-Gastaut Syndrome (LGS)
- (2009) Colin D. Ferrie et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Biologically Active Cannabinoids from High-PotencyCannabis sativa
- (2009) Mohamed M. Radwan et al. JOURNAL OF NATURAL PRODUCTS
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Therapeutic use ofCannabis sativaon chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
- (2008) F.C. MACHADO ROCHA et al. EUROPEAN JOURNAL OF CANCER CARE
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started